These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10848680)

  • 21. Muscle weakness in mechanically ventilated patients with severe asthma.
    Leatherman JW; Fluegel WL; David WS; Davies SF; Iber C
    Am J Respir Crit Care Med; 1996 May; 153(5):1686-90. PubMed ID: 8630621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
    Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of the non-depolarizing myorelaxant vecuronium bromide (norkuron) in children].
    Agavelian EG; Shaginian AK; Shabanova SK
    Anesteziol Reanimatol; 2007; (1):27-9. PubMed ID: 17460985
    [No Abstract]   [Full Text] [Related]  

  • 24. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
    Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
    Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary vasospasm during the reversal of neuromuscular block using neostigmine.
    Kido K; Mizuta K; Mizuta F; Yasuda M; Igari T; Takahashi M
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1395-6. PubMed ID: 16146484
    [No Abstract]   [Full Text] [Related]  

  • 26. Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: A pooled analysis of 26 studies.
    Herring WJ; Woo T; Assaid CA; Lupinacci RJ; Lemmens HJ; Blobner M; Khuenl-Brady KS
    J Clin Anesth; 2017 Sep; 41():84-91. PubMed ID: 28802619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of use of pyridostigmine and requirement of vecuronium in patients with myasthenia gravis.
    Tripathi M; Kaushik S; Dubey P
    J Postgrad Med; 2003; 49(4):311-4; discussion 314-5. PubMed ID: 14699228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sugammadex: something new to improve patient safety or simply a gadget?].
    Plaud B
    Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S64-9. PubMed ID: 19887280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The incidence of residual neuromuscular blockade associated with single dose of intermediate-acting neuromuscular blocking drugs.
    Kaan N; Kocaturk O; Kurt I; Cicek H
    Middle East J Anaesthesiol; 2012 Feb; 21(4):535-41. PubMed ID: 23327026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
    Geldner G; Niskanen M; Laurila P; Mizikov V; Hübler M; Beck G; Rietbergen H; Nicolayenko E
    Anaesthesia; 2012 Sep; 67(9):991-8. PubMed ID: 22698066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atracurium, cisatracurium, vecuronium and rocuronium in patients with renal failure.
    Della Rocca G; Pompei L; Coccia C; Costa MG; Cecchini V; Vilardi V; Pietropaoli P
    Minerva Anestesiol; 2003; 69(7-8):605-11, 612, 5. PubMed ID: 14564242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intractable Polyuria Mimicking Diabetes Insipidus-Source Traced to Vecuronium Infusion.
    Haldar R; Samanta S; Singla A
    Am J Ther; 2016; 23(2):e588-90. PubMed ID: 24736047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimum time for neostigmine administration to antagonize vecuronium-induced neuromuscular blockade.
    Kirkegaard-Nielsen H; Toft P; Severinsen IK; May O
    Eur J Anaesthesiol; 1995 Nov; 12(6):585-9. PubMed ID: 8665881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High concentration sevoflurane induction of anesthesia accelerates onset of vecuronium neuromuscular blockade.
    Yamaguchi S; Egawa H; Okuda K; Mishio M; Okuda Y; Kitajima T
    Can J Anaesth; 2001 Jan; 48(1):34-7. PubMed ID: 11212046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Indications and clinical use of sugammadex].
    Debaene B; Meistelman C
    Ann Fr Anesth Reanim; 2009 Sep; 28 Suppl 2():S57-63. PubMed ID: 19887279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of atracurium, cisatracurium and vecuronium during anaesthesia for laparoscopic surgery].
    Paśko-Majewska M; Owczuk R; Wujtewicz M
    Anestezjol Intens Ter; 2011; 43(1):9-13. PubMed ID: 21786523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interactions between mivacurium, rocuronium, and vecuronium during general anesthesia.
    Kim DW; Joshi GP; White PF; Johnson ER
    Anesth Analg; 1996 Oct; 83(4):818-22. PubMed ID: 8831328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vecuronium bromide and methylprednisolone succinate are physically incompatible!
    Prabhakar H; Ali Z; Rath GP; Sheikh IA
    J Neurosurg Anesthesiol; 2008 Apr; 20(2):153-4. PubMed ID: 18362782
    [No Abstract]   [Full Text] [Related]  

  • 39. The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive care unit.
    Frankel H; Jeng J; Tilly E; St Andre A; Champion H
    Am Surg; 1996 Jun; 62(6):503-6. PubMed ID: 8651538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative residual paralysis and respiratory status: a comparative study of pancuronium and vecuronium.
    Bissinger U; Schimek F; Lenz G
    Physiol Res; 2000; 49(4):455-62. PubMed ID: 11072806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.